Developed technology for early detection of 13 types of cancer from blood Toshiba Nov. 25 7:12
Toshiba has developed a new technology that can detect 13 types of cancer at an early stage through blood tests. It is characterized by being able to detect with high accuracy in a short time, and aims to be put into practical use within a few years.
This technology was developed by Toshiba in collaboration with Tokyo Medical University and the National Cancer Center.
By measuring the concentration of a molecule called “microRNA” secreted by many cancer cells in the blood, it is possible to detect 13 types of cancer, including pancreatic cancer, stomach cancer, and breast cancer.
In previous studies, the development of a dedicated small inspection device, etc. not only identified cancer and non-cancerous people with an extremely high accuracy of 99%, but also stage 0. It is said that it was found at the very early stage called. In addition, if it is put to practical use, it will be cheaper than other cancer tests using microRNA.
The company intends to proceed with verification tests from the next fiscal year and aim for practical use within a few years.
Koji Hashimoto, Research Leader of Toshiba's R & D Headquarters, said, “Cancer is the most common cause of death among Japanese people and is a major medical issue. Early detection of cancer is important for improving survival. I think that the mission is to put it to practical use. "